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Identity 
Note: Indeed, it is a normal elderly phenomenon in 
men over 60 years, to loose the Y chromosome. 
Clinics and pathology 
Disease 
-Y is frenquently observed in myeloproliferative 
diseases (MPD), myelodysplasic syndromes (MDS), 
and acute non lymphocytic leukemias (ANLL), but 
rarely in lymphoproliferation. 
Epidemiology 
Frequency of Y loss cases in the control and patient 
populations: 
- In the control population: 10.5% of the males as a 
whole, 0 to 2% before 60 years; 
- In myeloid diseases: 9.5% of MDS male patients, 
3.2% of ANLL male patients, and up to 10% of chronic 
myelogenous leukemia (CML) male patients. 
Percentage of -Y cells: 
- loss of the Y chromosome in 100% of the cells 
appears in about 20% of control cases who have lost 
their Y and about 30% of myeloid disease patients with 
a -Y karyotype; controls and MDS populations show 
comparable % values of missing Y cells; 
- In ANLL and in MPD the percentages are 
significantly higher than in the control population; this 
may partly be due to the swiftness of the monoclonal 
proliferation. 
Age: 
- In CML and in ANLL with a t(8;21), Y loss occurs at 
a younger age than in the normal population. 
- No significant difference was demonstrated between 
MDS patients and the control group in the unique study 
with statistical analysis. 
Clinics 
The functional significance of Y loss is at present 
unknown: 
- Partial or complete reappearance of the Y 
chromosome has been described in 8 cases of leukemia 
remissions showing that this abnormality may be a 
neoplastic event. 
- In CML, the occurrence of the Y loss does not 
indicate progression of the disease; it may be a sporadic 
event in both normal and CML populations in patients 
younger than 60 years. 
- In ANLL with t(8;21), Y is lost in 61% of men; in 
some of these cases, Y loss is in association with other 
well known secondary abnormalities; Y loss mosaicism 
in t(8;21) cells is observated in about 18% of males; X 
chromosome is lost in 41% of females; loss of sex 
chromosome is not elderly related in this disease. 
Cytology 
No particular assocition. 
Prognosis 
No clear relation between Y loss and the prognosis; as 
the age and the disease have a specific prognostic value 
affecting the clinical course, it will be difficult to 




The constitutive heterochromatin of the Y chromosome 
is the "bodyguard" of the genome (1975). 
Y loss may prevent other marrow cells from being 
involved in further karyotypic progression (1980). 
The gene for the receptor of GM-CSF is located on the 
pseudoautosomal region of the Y chromosome (1992). 
The Y chromosome contains a tumor suppressor gene 
(1994). 
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All available probes for the Y chromosome. 
Additional anomalies 
Y loss is generally considered as a secondary event, 
most often in association with t(9;22) in CML or with 
t(8;21) in M2 AML. 
Variants 
As a sole event, the loss of an X chromosome in 
females, -X, is much less frequent than the loss of the 
Y chromosome in males, but it may also occur. 
Genes involved and proteins 
Note 
Genes involved, if any, are unknown. 
To be noted 
Note 
All data herein evaluated were extracted from bone 
marrow studies; there is a difference between the active 
marrow progenitor cells and the stimulated 
phytohemagglutinin lymphocyte cell population; in one 
study on one individual, the Y loss rate had been found 
lower in peripherical cells in culture than in the bone 
marrow cells. 
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